In Vitro Exploration of Macrophage Migration Inhibitory Factor (MIF) as a Possible Agent of Lymphatic Dilation in the Pathogenesis of Lymphatic Filiariasis by Rosen, Lauren
University of Connecticut
OpenCommons@UConn
Honors Scholar Theses Honors Scholar Program
Spring 5-1-2008
In Vitro Exploration of Macrophage Migration
Inhibitory Factor (MIF) as a Possible Agent of
Lymphatic Dilation in the Pathogenesis of
Lymphatic Filiariasis
Lauren Rosen
University of Connecticut - Storrs, laurenrosen1@gmail.com
Follow this and additional works at: https://opencommons.uconn.edu/srhonors_theses
Part of the Life Sciences Commons, and the Medical Pathology Commons
Recommended Citation
Rosen, Lauren, "In Vitro Exploration of Macrophage Migration Inhibitory Factor (MIF) as a Possible Agent of Lymphatic Dilation in
the Pathogenesis of Lymphatic Filiariasis" (2008). Honors Scholar Theses. 54.
https://opencommons.uconn.edu/srhonors_theses/54
  
 
 
In Vitro Exploration of Macrophage Migration Inhibitory Factor (MIF) as a 
Possible Agent of Lymphatic Dilation in the Pathogenesis of Lymphatic Filiariasis 
 
 
 
University of Connecticut 
Senior Honors Thesis 
Lauren E Rosen 
May 2, 2008 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
In Vitro Exploration of Macrophage Migration Inhibitory Factor (MIF) as a 
Possible Agent of Lymphatic Dilation in the Pathogenesis of Lymphatic Filiariasis 
 
 
ABSTRACT 
 
   Macrophage Migration Inhibitory Factor (MIF) is a human cytokine that is well known 
for its role in modulating macrophage function.  It has also been shown to cause smooth 
muscle cell death.  A homolog of the MIF protein (BmMIF) has been found in Brugia 
malayi, one of the etiological agents of lymphatic filariasis.  BmMIF shares a significant 
portion of its sequence homology with human MIF.   Infection by Brugia malayi leads to 
a consistent finding of lymphatic dilation with surrounding smooth muscle cell apoptosis.  
We hypothesize that Brugia malayi releases BmMIF as a mediator of host smooth muscle 
cell death in the infected lymphatics in order to expand the lumen beyond normal 
anatomical dimensions.  Our goal is to express and purify recombinant BmMIF and to 
measure the protein’s effect on smooth muscle cells in culture.  
 
INTRODUCTION 
    
   Brugia malayi is an etiological agent of lymphatic filariasis, a disease that is 
predominant in the tropics and affects more than 120 million individuals worldwide.1  
Infection is spread through the bite of a mosquito containing L3 larvae.  The L3 migrate 
through the blood and enter the lymphatics and molt into L4, which in turn molt into 
adult parasites which reside in the lumen of the lymphatics.  The adult parasites produce 
microfilariae that migrate from the lymph back into the peripheral bloodstream.2  
Lymphatic filariasis is characterized by different categories of physical manifestations.  
Individuals with lymphatic filariasis present with a wide range of clinical signs; and may 
be asymptomatic, filaeremic or afilaraemic, or have clinical lymphangiectasia including 
both acute and chronic forms of the disease.1  In addition to the development of lymphatic 
filariasis, lymphangietasia due to filarial parasites forms a risk factor for additional 
chronic conditions such as lymphedema and elephantitis.5   As well, there are various 
psychological disorders that develop from the social stigma associated with the 
disfiguring nature of the disease.    
   One consistency in cases of lymphatic filariasis is lymphatic dilation.  Irregardless of 
the clinical manifestation, lymphatic dilation is observed in all patients prior to patency of 
infection.3  The dilation of the lymphatics is due to the distention of vessel walls caused 
by adult larvae.  The most commonly affected nesting location in the lymphatic 
circulation is the inguinal lymph node.4  Dilation of the lymphatics has been shown to be 
due to factors released by the parasite, the factor most likely being an excretory-secretory 
(ES) product of the parasite.  Furthermore, lymphangietasia is not limited to the precise 
location of the L4 nest, contributing to the theory that the causal agent of dilation is likely 
an excretory-secretory (ES) product of the parasite.1 Dilation of the lymphatics can be 
induced by infecting SCID mice with Brugia malayi, and reversed by either removing or 
killing the worms, indicating the independence of this process from the host immune 
response.5  
 
   Macrophage Migration Inhibitory Factor is a known human cytokine and acts as an 
inhibitor of random macrophage migration and thus enhances the retention of 
macrophages in tissues leading to the development of inflammation.  In addition to 
immunological functions, MIF has also been implicated for a role in smooth muscle cell 
death.  Taylor et. al has demonstrated that a null mutation in the MIF protein of mice 
prevents the death of bladder smooth muscle cells both in vivo and in vitro in the case of 
partial bladder outlet obstruction.  Following take down, mice rendered null for the MIF 
were found to have increased muscle mass of the bladder of up to 40% in relation to 
wild-type mice.  Primary bladder smooth muscle cultures treated with recombinant MIF 
exhibited an increased proportion of apoptotic cells seen on flow cytometry.  Nucleated 
muscle counts in the bladder were 22% lower in wild-type mice than in MIF knock outs, 
indicating a loss of smooth muscle associated with the presence of MIF.6 This study was 
the first of its kind to elucidate the role of MIF in smooth muscle cell death.  The impact 
of the protein on muscle survival and apoptosis was previously unknown.    
   An ES product of Brugia malayi and Wuchereria bancrofti, another filarial parasite that 
causes lymphatic filariasis, has been identified that has significant sequence homology 
with human MIF. Both BmMIF and human MIF show similar catalytic, structural, and 
physical properties.2  While BmMIF is present in the ES products of all stages of the 
parasite lifecycle, its expression is enhanced in the adult stage, the stage at which 
lymphatic dilation is observed.2  Antibodies to BmMIF are high in uninfected individuals 
residing in endemic areas, indicating that immunity to lymphatic filariasis may be due to 
host recognition of BmMIF.8   
   If the sequence homology of human MIF and BmMIF is reflected in similar activity, 
then we expect BmMIF to be the mediator of smooth muscle cell death surrounding 
lymphatic vessels in lymphatic filariasis.  The hypothesis is tested by expressing and 
purifying recombinant BmMIF and plating the protein on smooth muscle cell cultures.  
Recombinant BmMIF was prepared with the use of a pEXP5-NT/TOPO plasmid cloning 
reaction and expression was enhanced with isopropyl β-D-1-thiogalactopyranoside 
(IPTG).  Various experiments were performed to determine the best method of protein 
purification.  Ultimately, purification was performed with a nickel affinity column. 
Smooth muscle cell cultures were prepared by plating isolated cells obtained from the 
aortas of green florescent protein (GFP) positive mice.   GFP fluoresces when exposed to 
blue light and is a commonly used biosensor for measuring gene expression.  The lytic 
affect of both recombinant BmMIF and adult Brugia malayi parasites was measured by 
placing either recombinant protein or adult parasites on confluent cultures of smooth 
muscle cells and comparing the number of live smooth muscle cells pre and post-
addition.  To assess the biological activity of purified recombinant BmMIF, a macrophage 
migration inhibitory assay was used.  
 
METHODS 
 
Recombinant BmMIF Purification 
 
   The initial recombinant BmMIF protein obtained had been cloned into a BL21 vector 
by Dr. TV Rajan.  Chemical precipitation techniques were used to purify and isolate the 
protein of interest from an overnight culture of BL21.  Differing volumes of 200-proof 
ethanol were added to BL21 lysate solutions.  Following incubation at 0°C the samples 
were spun down in a microcentrifuge and the pellet and supernatant were separated.  
Both the pellet and supernatant were resuspended in 1% SDS sample buffer and were 
analyzed on a 12.5% PAGE gel with SDS gel electrophoresis.  Subsequent chemical 
precipitation was carried out with ammonium sulfate by a similar procedure.   
   Chemical precipitation was followed by column separation of the BL21 lysate with a 
DE-22 column.  The pH of the lysate was adjusted to alkaline conditions with NaOH. 
The pH of the DE-22 beads was brought to alkaline conditions with phosphoric acid.  The 
beads were loaded into the column and were washed with phosphate buffer.  1 mL of  
BL21 lysate loaded onto the column and the eluent was collected in 0.2 mL fractions.  
The fractions were analyzed with SDS-PAGE on a 12.5% gel.   
   A soluble – insoluble preparation was performed to determine the solubility of BmMIF 
in order to determine how to best proceed with protein purification.  Cells obtained from 
an overnight culture of BL21 were spun down and the pellet was isolated.  Lysis buffer 
was added to the pellet and the sample was freeze-thawed for three cycles in ice cold 
ethanol and a 42°C water bath.  The sample was centrifuged to pellet insoluble protein 
and the supernatant was transferred to a separate tube.  Both the supernatant and pellet 
were resuspended in SDS buffer and run on a 12.5% PAGE gel.   
 
Expression and Purification of BmMIF in a pEXP5-NT/TOPO Vector 
 
   In order to enhance the ease of expression and purification, BmMIF was re-cloned into 
a pEXP5-NT-TOPO vector, which facilitates purification by Ni-affinity chromatography. 
(Figure 1.1)  The cloning of BmMIF was performed by Dr. TV Rajan. The plasmid was 
analyzed with a miniprep procedure and then transformed into BL21.  Plasmids were 
mixed with BL21, heat-shocked, and incubated in AMP medium in a 37°C shaker 
overnight. (Figure 1.2)  The expression of the transformed plasmid was then enhanced by 
the addition of IPTG.    
 
 
 
 
 
 
 
 
 
 
 
 
 
Figures 1.1 & 1.2: pEXP5-NT/TOPO plasmid map and 
diagram of cloning site.  The pEXP5-NT/TOPO vector 
contains a Tobacco Etch Virus (TEV) recognition site that allows for the removal of the attached N-
terminal tag from generated recombinant proteins.   
 
   The newly expressed BmMIF was purified using a combination of nickel column 
separation and dialysis.  The Ni-NTA column was washed with a series of buffers and 
lysed BL21 was loaded onto the column. The tagged protein was eluded with buffer E 
Figure 1.1 
Figure 1.2 
(100mM NaH2PO4, 100mM Tris⋅Cl, 8M Urea, pH 4.53) in 20 uL aliquots.  The samples 
containing the most protein as identified by running an SDS PAGE gel were pooled and 
dialyzed slowly against buffer E without denaturant.  Hydrogen peroxide was added to 
the buffer to help refold the protein.  The concentration of BmMIF in the dialyzed sample 
was quantified by comparing a known volume of sample to differing concentrations of 
lysozyme on an SDS page gel.  The vector derived N-terminal tag containing the poly-his 
sequence was cleaved from the recombinant BmMIF using acTEV protease.  
 
Assessment of Recombinant BmMIF Activity on Smooth Muscle Cell Cultures 
 
   Smooth muscle cell cultures were derived from the digestion of GFP positive mice 
aorta.  In this particular strain of mice, GFP expression is driven by a smooth muscle cell 
specific promoter Following take-down in a CO2 chamber, the heart and attached aorta 
were removed from the mice and placed in cold sterile PBS buffer.  The surrounding 
tissue (fat and adventitia) was removed from the aorta under a dissecting microscope.  
The cleaned aortas were cut into fine pieces and added to a sterilized solution of 5mg 
collagenase A, and 1mg of elastase in 10mL of PBS.  The aortas and enzyme mixture 
were placed in a shaker at 37 °C for one hour, followed by centrifugation at 1600rpm for 
5 minutes.  The supernatant was removed from the sample and the volume was brought 
up to 40mL with sterile fetal calf serum plus penstrip.  The cells, maintained in a solution 
of DMEM, 10% FCS, and Penstrip, were added to a Petri dish and placed into an 
incubator until confluent.  Smooth muscle cells were identified and characterized by light 
microscopy.      
   The medium was removed from the culture with a vacuum line and 10ml of sterile PBS 
was added to reduce the concentration of serum protein.  A 1.5mL solution of trypsin in 
EDTA was added to the cells to disrupt plate binding.  2mL of DMEM medium was then 
added to the cells to kill trypsin.  Cells were counted with a Hemacytometer and there 
was determined to be 4x104 cells/mL in each well of a 12 well cluster dish.  The cells 
were allowed to reach confluency and were subsequently serum-starved for 24 hours.  0, 
10, 25, 50, and 100ng recombinant BmMIF/mL was added in to each well in duplicate.  
Cells were analyzed with a florescent scope to determine smooth muscle cell necrosis.       
   Additionally, smooth muscle cell cultures from aorta and adipose tissue were 
trypsinized and frozen in DMSO.  About one week prior to the arrival of Brugia malayi 
adult worms, an ampule of frozen cells of each cell line was thawed.  Two days prior to 
the arrival of worms, the cells in the ampules were trypsinized and two wells of each 
smooth muscle cell type were plated on to 6-well culture plates.  Approximately 4 adult 
worms, both male and female, were plated in one of the wells of each cell type.  After 
five days the media containing worms was removed and the cells were incubated with 
trypsin until they were mobilized off of the plate.  The number of living smooth muscle 
cells in each culture plated with adult worms was compared to the number of live cells in 
control wells.     
 
Macrophage Migration Inhibitory Assay 
 
   Macrophages of cell lines RAW and J (obtained from ATCC) were grown up in cluster 
dishes.  Once cells reached confluency, the cells were mobilized off of the wells and spun 
down.  The cells were pipetted into hematocrit tubes and spun for 5 minutes.  The 
hematocrit tubes were broken at the cell – serum interface and the ends containing settled 
macrophages were adhered with silicon gel at the closed end to the center of the well of a 
six well clusterdish.  Three wells were prepared for each cell line for a total of six wells.  
Media containing recombinant BmMIF and media containing recombinant protein PigR 
were  added individually to one well of each cell line.  Media was added to the last set of 
wells to serve as a control.  The dish was observed for a period of a few days following 
set-up and the distance of macrophage migration out of the end of the capillary tube was 
observed and recorded.   
    
RESULTS 
 
Recombinant BmMIF Purification 
   Attempts at chemical precipitation were unsuccessful.  In both ethanol and ammonium 
sulfate precipitations, BmMIF was not significantly purified from other bacterial proteins.  
From these findings it was concluded that chemical precipitation is an inefficient mode of 
BmMIF purification. (Figure 2) 
Figures 2.1 & 2.2: PAGE gels of chemical precipitation with EtOH and ammonium sulfate.  Lanes 5 (60% 
EtOH precipitation pellet) and 7 (80% EtOH precipitation pellet) of the EtOH purification gels show an 
almost identical banding pattern to the unprecipitated BL21 lysate in lane 2.  Lane 3 (40% EtOH 
precipitation pellet) shows one strong high molecular weight band, but this is too large to correspond to the 
BmMIF protein.  MIF has a molecular weight of approximately 13Kd. The band may however represent a 
BmMIF dimer.  Lanes 4, 6, and 8 contain very little protein, indicating that most proteins were isolated in 
the pellets.  Lanes 3 – 6 of the ammonium sulfate precipitation gel show no significant difference in 
banding pattern or density from the unpurified BL21 lysate.  
 
   The DE-22 anion exchange column proved to be an inadequate method to purify 
BmMIF as well. The protein eluted as expected with the phosphate buffer washes, but 
was accompanied by an abundance of other bacterial proteins.  Repeated trials of De-22 
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purification were unsuccessful and the results mirrored those previously described. 
(Figure 3)   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3: PAGE gel of DE-22 column As indicated by the presence of bands in the flow through lanes 4 
and 5, not all proteins were fully bound to the column.  Perhaps the column was overloaded with sample.  
The majority of protein eluded in the first three elutions, E1-E3.  No significant difference in banding 
pattern was found between the elutions and the BL21 lysate.    
 
Expression and Purification of BmMIF in a  pEXP5-NT-TOPO Vector 
 
   PCR followed by plasmid insertion was successful with the miniprep procedure 
identifying a clean band at the expected molecular size of plasmid plus DNA sequence. 
SDS page analysis of a BL21 culture following plasmid transformation revealed a protein 
of the expect molecular weight for the BmMIF protein plus BL21. (Figures 4.1 and 4.2) 
   The use of a nickel column facilitated the isolation of BmMIF from associated bacterial 
proteins.  The tagged protein had an affinity towards the nickel beads, and eluted during 
late buffer washes. Dialysis became necessary to remove urea present in the elution 
buffers of the nickel column.  Dialysis proved to be a timely procedure, and resulted in 
the loss of a large fraction of the purified BmMIF.  (Figure 5) 
   Based on comparison with known concentrations of lysozyme, the concentration of 
BmMIF in solution was low.  Addition of AcTEV protease to remove the N-terminal tag 
from the purified recombinant protein resulted in cleavage, although incomplete, of the 
N-terminal tag.   
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  Figures 4.1 & 4.2: Miniprep results from generation of cDNA plasmid and PAGE gel results of plasmid 
transformation.  The agarose gel prepared for the miniprep confirms the success of plasmid insertion.  In 
the sample lane containing the plasmid reaction, distinct and clear bands can be seen that represent the 
cDNA plasmid, the supercoiled plasmid, and degraded RNA.  The cDNA plasmid band is found at the 
expected molecular weight of the TOPO vector and incorporated PCR amplified  BmMIF.  SDS page 
results from plasmid transformation demonstrate in lane 4 a strong band representative of BL21 and the 
encorporated plasmid.  This band appears slightly larger than that in lane 3, representing BL21 transformed 
with a smaller vector other than pEXP5-NT-TOPO. 
 
Figure 5:  Ni-affinity column chromatography facilitated clean purification of recombinant BmMIF.  The 
absence of a BmMIF molecular weight band in the flow through sample indicates that all BmMIF was 
bound to the column.  Bacterial proteins and dimerized BmMIF eluted in the flow through and in buffer C 
and D washes.  Recombinant BmMIF eluted solely and independently in the buffer E washes. 
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Figure 4.1 Figure 4.2 
Assessment of Recombinant BmMIF Activity on Smooth Muscle Cell Cultures 
 
   The affect of recombinant BmMIF on smooth muscle cells was inconclusive.  There 
appeared to be significant ballooning and clustering of cells corresponding to the addition 
of higher protein concentrations.  Under the florescent scope, there appeared to be a 
slightly lower proportion of GFP positive smooth muscle cells (smooth muscle cells 
expressing the green florescent protein) in the wells with a higher addition of BmMIF.  
The counting of dead and viable cells was not possible with the florescent scope, and 
would ideally require flow cytometry.  The second batch of smooth muscle cell cultures 
were prepared from both mice aorta and uteri, however both cultures died before we were 
able to add any BmMIF 
  From the smooth muscle cell cultures incubated with adult worms, it was found that the 
wells to which worms were added contained fewer cells than control wells to which no 
worms were added.  In all three of the control wells, there were 1x105 cells per ml of live 
smooth muscle cells.  One of the wells incubated with worms contained no live worms.  
The remaining two wells incubated with worms contained approximately 3x104 cells per 
ml each.  A second trial of this experiment yielded very similar results.  In the three wells 
to which no worms were added, the live cell number was 3x105 cells per ml.  The three 
wells containing B. malayi adults all contained less than 1x104 cells per ml.   
 
Macrophage Migration Inhibitory Assay 
 
   Results from numerous trials have proven to be inconclusive, with no significant 
difference in cell migration observed between control and BmMIF samples.  In all wells, 
there was found to be a bubble of macrophages emerging from the tip of the hematocrit 
tubes.  These bubbles were visualized under high power field of a light microscope, and 
were not measured but noted by presence and relative size.  Both recombinant BmMIF 
and PigR induced a similar pattern of cell migration.  This finding is unexpected, and 
may indicate an error in assay method or analysis.  PigR has no known affect on the 
motility of macrophages and it is expected to find a trail of cells emerging from the 
hematocrit tube.  It was expected that BmMIF inhibit the migration of macrophages, and 
that the movement of macrophages from the hematocrit tube into the surrounding 
medium would be retarded.   
 
CONCLUSION 
 
   Despite the wide range of clinical manifestations, no optimal diagnostic technique 
exists for lymphatic filariasis.  Compared to other parasitic diseases, details of the 
mechanism of Brugia malayi infection are scarce. There exists a current lack of 
understanding of the pathway that leads to the development of lymphatic filariasis, and 
the maintenance of chronic versus acute infection.  The function of Bm-MIF and the 
mechanism of its formation are relatively unknown.2  By elucidating a function of Bm-
MIF-1 in host-parasite interaction, we can gain crucial knowledge that may assist in the 
development of novel therapies and vaccines targeting filarial parasites.  An 
understanding of the role of Bm-MIF in host-parasite interaction will also function to 
increase current understanding of the disease mechanism. 
   We have developed a method that once optimized, has the potential to result in 
expression and purification of BmMIF.  The cloning of BmMIF into an NT/TOPO vector 
encoding an N-terminal polyhistidine tag facilitated and simplified the process of protein 
purification using Ni-affinity column chromatography.  Since recombinant BmMIF was 
eluted from the Ni column in a buffer containing a high concentration of urea, it was 
necessary to dialyze the purified protein prior to measuring its affect on smooth muscle 
cells in culture.  A significant proportion of BmMIF was lost during dialysis.  Ideally the 
dialysis procedure could be modified to decrease protein loss, or the protein could be 
eluted from the column utilizing a lower concentration buffer.  The presence of urea in 
buffer E may also possibly contribute to the modification of proper BmMIF folding.   
   We hypothesized that a protein produced by adult worms of Brugia malayi plays a role 
in the pathogenesis of lymphatic filariasis by causing smooth muscle cell death in the 
muscle layer surrounding the lymphatics, thus allowing the worms to multiply and the 
disease to propagate.  The destruction of smooth muscle cells following incubation with 
adult B. malayi and the inconclusive findings of cell cultures incubated with purified 
recombinant BmMIF is suggestive of the following.  Either BmMIF has the potential to 
cause smooth muscle cell death and the inconclusive results of incubated with 
recombinant protein are due to protein misfolding or inactivation that occurred during the 
purification procedure, or adult Brugia malayi parasites have the ability to kill smooth 
muscle cells independently of BmMIF.    
   Our results indicated that adult worms do indeed cause smooth muscle cell death.  The 
worms are most likely to cause cell death by the release of a secretory-excretory product.  
However, his product may or may not be BmMIF.    The inconclusive affect of purified 
recombinant BmMIF on smooth muscle cell culture is likely due to protein inactivation.  
The protein was exposed to numerous chemicals and reagents during purification that 
may have resulted in protein misfolding or perhaps even denaturation.  
   In order to confirm the hypothesis of protein inactivation, the activity of the purified 
BmMIF was measured using a macrophage migratory inhibition assay.  The results of the 
assay, although inconclusive, suggest that the purified BmMIF may indeed be inactive.  
No inhibition of macrophage migration was observed for BmMIF in the assay, but 
measurements were relative and the procedure itself outdated.   
   To better assess the bioactivity profile of the purified BmMIF, we must develop a more 
valid and reliable assessment tool.  Here we propose a modification and updating of the 
macrophage migratory inhibition assay.  This assay was developed in the 1960s and has 
remained almost unchanged since this time.  In the meanwhile, other biochemical 
methods and experimental techniques have been entirely changed, leaving the assay 
behind.  The assay needs to be improved such that the measurement of macrophage 
migration is more quantitative, and the set-up simpler so there is no worry of disturbing 
set macrophages when medium is added to the wells.     
   We have preliminary evidence that B. malayi adult parasites kill smooth muscle cells in 
culture.  As of yet, we have been unable to reproduce these effects with purified BmMIF.  
If the protein proves to be inactive, then the purification procedure will be modified to 
prevent future inactivation of the recombinant protein.  Following the determination of 
the status of the purified protein, the effect of BmMIF on smooth muscle cell cultures will 
continue to be investigated.   Further time and effort must be placed into developing an 
effective migration chamber assay in order to do so.   
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